These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31929426)
1. From Nonadherence to Adherence. Kuypers DRJ Transplantation; 2020 Jul; 104(7):1330-1340. PubMed ID: 31929426 [TBL] [Abstract][Full Text] [Related]
2. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome. Kuypers DRJ Clin Pharmacol Ther; 2020 Feb; 107(2):347-358. PubMed ID: 31449663 [TBL] [Abstract][Full Text] [Related]
3. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372 [TBL] [Abstract][Full Text] [Related]
4. Subclinical Antibody-Mediated Rejection. Arias M; Serón D; Herrero I; Rush DN; Wiebe C; Nickerson PW; Ussetti P; Rodrigo E; de Cos MA Transplantation; 2017 Jun; 101(6S Suppl 1):S1-S18. PubMed ID: 28538291 [No Abstract] [Full Text] [Related]
5. The Importance of Bringing Transplantation Tolerance to the Clinic. Cosimi AB; Ascher NL; Emond JC; Kaufman DB; Madsen JC; Miller J; Monaco AP; Montgomery RA; Newell KA; Sánchez-Fueyo A; Sarwal MM; Scandling JD; Strober S; Todo S; Weir MR; Sachs DH Transplantation; 2021 May; 105(5):935-940. PubMed ID: 33901128 [No Abstract] [Full Text] [Related]
6. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. McGillicuddy JW; Chandler JL; Sox LR; Taber DJ Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922 [TBL] [Abstract][Full Text] [Related]
7. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Hugon A; Roustit M; Lehmann A; Saint-Raymond C; Borrel E; Hilleret MN; Malvezzi P; Bedouch P; Pansu P; Allenet B Transplantation; 2014 Jul; 98(2):222-8. PubMed ID: 24926826 [TBL] [Abstract][Full Text] [Related]
8. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial. Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320 [TBL] [Abstract][Full Text] [Related]
9. Annual literature review of donor-specific HLA antibodies after organ transplantation. Kaneku H Clin Transpl; 2011; ():311-8. PubMed ID: 22755424 [TBL] [Abstract][Full Text] [Related]
10. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients. Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524 [TBL] [Abstract][Full Text] [Related]
11. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. Cheng EY; Kaneku H; Farmer DG Clin Transpl; 2014; ():153-9. PubMed ID: 26281140 [TBL] [Abstract][Full Text] [Related]
12. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Serper M; Patzer RE; Reese PP; Przytula K; Koval R; Ladner DP; Levitsky J; Abecassis MM; Wolf MS Liver Transpl; 2015 Jan; 21(1):22-8. PubMed ID: 25312406 [TBL] [Abstract][Full Text] [Related]
14. Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation. Velidedeoglu E; Cavaillé-Coll MW; Bala S; Belen OA; Wang Y; Albrecht R Transplantation; 2018 Jun; 102(6):e257-e264. PubMed ID: 29470345 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958 [TBL] [Abstract][Full Text] [Related]
16. Prevention of antibody-mediated kidney transplant rejection. Morath C; Opelz G; Zeier M; Süsal C Transpl Int; 2012 Jun; 25(6):633-45. PubMed ID: 22587522 [TBL] [Abstract][Full Text] [Related]
17. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Massey EK; Tielen M; Laging M; Timman R; Beck DK; Khemai R; van Gelder T; Weimar W Transplantation; 2015 Feb; 99(2):375-80. PubMed ID: 25606787 [TBL] [Abstract][Full Text] [Related]
18. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients. Everly MJ Clin Transpl; 2011; ():333-6. PubMed ID: 22755427 [TBL] [Abstract][Full Text] [Related]
19. Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation. Maldonado AQ; West-Thielke P; Dew MA; Peipert JD; Heldenbrand S; Kaiser TE; Chisholm-Burns M; Potter LM; Clin Transplant; 2018 Sep; 32(9):e13362. PubMed ID: 30053319 [TBL] [Abstract][Full Text] [Related]
20. Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience. Gheith O; Al-Otaibi T; Halim MA; Mahmoud T; Nair P; Monem MA; Al-Waheeb S; Hassan R; Nampoory N Exp Clin Transplant; 2017 Feb; 15(Suppl 1):150-155. PubMed ID: 28260457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]